IL6R and autoimmune uveitis: Advances in understanding autoimmune uveitis pathomechanisms have led to the use of more specific treatments, including biological immune-modulating agents such as Tumor Necrosis Factor (TNF)-α blockers [5–7], Cluster of Differentiation (CD)20 antagonists [8], and Interleukin-6-Receptor (IL-6R) antibodies [9, 10].